> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-23/
- Published: 2020-11-08T12:00:00.000Z
- Updated: 2026-09-14T16:35:32.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144532

[**Draft Guide on Population Pharmacokinetics**](https://www.fdaweb.com/login.php?sa=v&aid=D5144517&cate=FR&stid=%241%241I4..m%2F.%24OVFGgUlXjLCPcCq.ZYKZ8%2F)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Population Pharmacokinetics (PK)” to assists sponsors in applying PK during drug development. 09/25/2020

[**Draft Guide on Hormonal Drug Product Development**](https://www.fdaweb.com/login.php?sa=v&aid=D5144519&cate=FR&stid=%241%241I4..m%2F.%24OVFGgUlXjLCPcCq.ZYKZ8%2F)  
*Federal Register* notice: FDA releases a draft guidance on Hormonal Contraceptive Drug Product Development. 09/25/2020

[**Guide on IDE Live Case Presentations**](https://www.fdaweb.com/login.php?sa=v&aid=D5144506&cate=FR&stid=%241%241I4..m%2F.%24OVFGgUlXjLCPcCq.ZYKZ8%2F)  
*Federal Register* notice: FDA makes available a guidance entitled “Live Case Presentations During Investigational Device Exemption (IDE) Clinical Trials.” 09/24/2020

[**Draft Guide on Harmonizing Drug Compendial Standards**](https://www.fdaweb.com/login.php?sa=v&aid=D5144507&cate=FR&stid=%241%241I4..m%2F.%24OVFGgUlXjLCPcCq.ZYKZ8%2F)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Harmonizing Compendial Standards with Drug Application Approval Using the USP Pending Monograph Process.” 09/23/2020

[**Draft Guide on Inactive Ingredient Database**](https://www.fdaweb.com/login.php?sa=v&aid=D5144508&cate=FR&stid=%241%241I4..m%2F.%24OVFGgUlXjLCPcCq.ZYKZ8%2F)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Using the Inactive Ingredient Database.” 09/23/2020

[**11 ‘No-Longer-Marketed’ NDAs Withdrawn** ](https://www.fdaweb.com/login.php?sa=v&aid=D5144479&cate=FR&stid=%241%241I4..m%2F.%24OVFGgUlXjLCPcCq.ZYKZ8%2F)*Federal Register* notice: FDA withdraws approval of 11 NDAs from multiple applicants because the products are no longer marketed. 09/22/2020